Yesilda Balavarca

Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations Lei Huang1, Lina Jansen1,2, Yesilda Balavarca3, Esther Molina-Montes4, Masoud Babaei1, Lydia van der Geest5, Valery Lemmens5, Liesbet Van Eycken6, Harlinde De Schutter6, Tom B Johannesen7, Claus W Fristrup8, Michael B Mortensen9, Maja Primic-Žakelj10, Vesna Zadnik10, Nikolaus Becker11, Thilo Hackert12, Margit Mägi13, Tiziana Cassetti14, Romano Sassatelli14, Robert Grützmann15,...

1. Lasry, A., Zinger, A. & Ben-Neriah, Y. Inflammatory networks underlying colorectal cancer. Nat. Immunol. 17, 230–240 (2016). 2. Farraye, F. A., Odze, R. D., Eaden, J. & Itzkowitz, S. H. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138, 746–774, 774.e1–774.e4; quiz e12–e13 (2010). 3. Chan, A. T. et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294, 914–923 (2005). 4. Chan, A. T.

Objective Resection can potentially cure resectable pancreatic cancer (PaC) and significantly prolong survival in some patients. This large-scale international study aimed to investigate variations in resection for PaC in Europe and USA and determinants for its utilisation. Design Data from six European population-based cancer registries and the US Surveillance, Epidemiology, and End Results Program database during 2003–2016 were analysed.